Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
InflaRx N.V | IFRX | Nov 27, 2024 | 2.40 | +9.09 |
Inflection Point Acquisition II | IPXX | Nov 27, 2024 | 10.82 | +0.42 |
Inflection Point Acquisition II Unit | IPXXU | Nov 27, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Nov 27, 2024 | 2.64 | +45.05 |
Informatica | INFA | Nov 27, 2024 | 26.39 | -0.79 |
Information Services Group | III | Nov 27, 2024 | 3.66 | +1.67 |
Information Technology ETF Vanguard | VGT | Nov 27, 2024 | 616.76 | -1.03 |
Infosys ADR | INFY | Nov 27, 2024 | 22.74 | -1.90 |
InfuSystems | INFU | Nov 27, 2024 | 8.86 | -1.01 |
ING Group ADR | ING | Nov 27, 2024 | 15.27 | +1.13 |
Ingersoll Rand | IR | Nov 27, 2024 | 104.05 | -0.66 |
Ingevity | NGVT | Nov 27, 2024 | 47.73 | +0.46 |
Ingles Markets A | IMKTA | Nov 27, 2024 | 73.34 | -1.16 |
Ingram Micro Holding Corp | INGM | Nov 27, 2024 | 22.53 | 0.00 |
Ingredion | INGR | Nov 27, 2024 | 147.03 | -1.19 |
Inhibikase Therapeutics | IKT | Nov 27, 2024 | 2.73 | +15.68 |
Inhibrx Biosciences | INBX | Nov 27, 2024 | 15.63 | +1.17 |
InMed Pharmaceuticals | INM | Nov 27, 2024 | 4.30 | -5.08 |
InMode | INMD | Nov 27, 2024 | 19.49 | +1.25 |
INmune Bio | INMB | Nov 27, 2024 | 4.89 | +0.20 |
Innate Pharma ADR | IPHA | Nov 27, 2024 | 1.50 | 0.00 |
Inno Holdings | INHD | Nov 27, 2024 | 4.89 | -7.11 |
Innodata | INOD | Nov 27, 2024 | 38.33 | -5.05 |
Innospec | IOSP | Nov 27, 2024 | 117.66 | +0.01 |
InnovAge | INNV | Nov 27, 2024 | 4.80 | +0.63 |
Innovate | VATE | Nov 27, 2024 | 5.86 | -4.40 |
Innovation Beverage Group | IBG | Nov 27, 2024 | 1.24 | 0.00 |
Innovative Eyewear | LUCY | Nov 27, 2024 | 6.51 | -5.38 |
Innovative Industrial Properties | IIPR | Nov 27, 2024 | 109.17 | +0.02 |
Innovative Industrial Properties A Pref | IIPR-A | Nov 27, 2024 | 26.27 | -0.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.